Bionomics Limited Financials

Bionomics Stock Summary

Bionomics competes with Pharmather Holdings, and Intelgenx Technologs. Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia. Bionomics is traded on OTC Exchange in the United States.

Bionomics Key Financial Ratios

There are many critical financial ratios that Bionomics' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Bionomics Limited reports annually and quarterly.

Bionomics Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Bionomics's current stock value. Our valuation model uses many indicators to compare Bionomics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bionomics competition to find correlations between indicators driving Bionomics's intrinsic value. More Info.Bionomics Limited is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bionomics' earnings, one of the primary drivers of an investment's value.

Bionomics Market Pulse

Along with financial statement analysis, the daily predictive indicators of Bionomics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bionomics Limited. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bionomics Limited based on widely used predictive technical indicators. In general, we focus on analyzing Bionomics Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bionomics's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

If you are still planning to invest in Bionomics Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bionomics' history and understand the potential risks before investing.